先天免疫系统
神经科学
神经炎症
疾病
免疫系统
医学
免疫学
生物
免疫
获得性免疫系统
小胶质细胞
炎症
病理
作者
Giulia Cisbani,Serge Rivest
标识
DOI:10.1038/s41380-021-01083-4
摘要
Innate immunity has been the focus of many new directions to understand the mechanisms involved in the aetiology of brain diseases, especially Alzheimer's disease (AD). AD is a multifactorial disorder, with the innate immune response and neuroinflammation at the forefront of the pathology. Thus, microglial cells along with peripheral circulating monocytes and more generally the innate immune response have been the target of several pre-clinical and clinical studies. More than a decade ago, inhibiting innate immune cells was considered to be the critical angle for preventing and treating brain diseases. After the failing of numerous clinical trials and the discovery that it may actually be the opposite in various pre-clinical models, the field has changed considerably. Here, we present both sides of the story with a particular emphasis on the beneficial properties of innate immune cells and how they can be targeted to have neuroprotective properties.
科研通智能强力驱动
Strongly Powered by AbleSci AI